HGSOC

Dual Evolutionary Pathways of Genomic Structural Diversity in High-Grade Serous Ovarian Cancer (HGSOC) and Their Impact on Patient Prognosis

by
Dual Evolutionary Pathways of Genomic Structural Diversity in High-Grade Serous Ovarian Cancer (HGSOC) and Their Impact on Patient Prognosis

Recent studies reveal a “dual evolutionary” pattern in pancreatic cancer similar to that of ovarian cancer: the HRD pathway is primarily characterized by DNA deletions, while the WGD pathway drives tumor malignancy through chromosomal fragmentation and ecDNA amplification. Key findings include that mitochondrial mutations significantly affect prognosis (with a hazard ratio of 3.1), and CDK12 … Read more

GCC Certification in the Gulf Region

by
GCC Certification in the Gulf Region

GCC stands for the Gulf Cooperation Council. This council was established in May 1981 in Abu Dhabi, UAE, and its member countries include Saudi Arabia, Kuwait, the United Arab Emirates, Qatar, the Sultanate of Oman, and the Kingdom of Bahrain. GCC certification refers to the certification requirements that must be met for specific products to … Read more

Molecular Markers of Low-Grade Serous Ovarian Cancer

by
Molecular Markers of Low-Grade Serous Ovarian Cancer

Approximately 90% of ovarian malignancies are epithelial ovarian cancer (EOC), with serous ovarian cancer (SOC) accounting for about 75% of EOC. In 2014, the World Health Organization (WHO) classified SOC into Type I and Type II based on histological findings under ordinary microscopy and biological behavior: Type I refers to low-grade serous ovarian cancer (LGSOC), … Read more